The role of insulin resistance in experimental diabetic retinopathy: genetic and molecular aspects

Background Diabetic retinopathy is characterized by defects in the retinal neurovascular unit. The underlying mechanisms of impairment-including reactive intermediates and growth-factor dependent signalling pathways and their possible interplay are incompletely understood. This study aims to assess...

Full description

Saved in:
Bibliographic Details
Main Authors: Järgen, Patrick (Author) , Dietrich, Axel (Author) , Herling, Andreas W. (Author) , Hammes, Hans-Peter (Author) , Wohlfart, Paulus (Author)
Format: Article (Journal)
Language:English
Published: June 2, 20217
In: PLOS ONE
Year: 2017, Volume: 12, Issue: 6, Pages: 1-17
ISSN:1932-6203
DOI:10.1371/journal.pone.0178658
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1371/journal.pone.0178658
Verlag, kostenfrei, Volltext: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0178658
Get full text
Author Notes:Patrick Järgen ; Axel Dietrich ; Andreas W. Herling ; Hans-Peter Hammes ; Paulus Wohlfart

MARC

LEADER 00000caa a2200000 c 4500
001 157679735X
003 DE-627
005 20240925091823.0
007 cr uuu---uuuuu
008 180625s2017 xx |||||o 00| ||eng c
024 7 |a 10.1371/journal.pone.0178658  |2 doi 
035 |a (DE-627)157679735X 
035 |a (DE-576)50679735X 
035 |a (DE-599)BSZ50679735X 
035 |a (OCoLC)1341012098 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Järgen, Patrick  |d 1988-  |e VerfasserIn  |0 (DE-588)1161675299  |0 (DE-627)1025137132  |0 (DE-576)50679640X  |4 aut 
245 1 4 |a The role of insulin resistance in experimental diabetic retinopathy  |b genetic and molecular aspects  |c Patrick Järgen ; Axel Dietrich ; Andreas W. Herling ; Hans-Peter Hammes ; Paulus Wohlfart 
264 1 |c June 2, 20217 
300 |a 17 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published: June 2, 2017 
500 |a Gesehen am 25.06.2018 
520 |a Background Diabetic retinopathy is characterized by defects in the retinal neurovascular unit. The underlying mechanisms of impairment-including reactive intermediates and growth-factor dependent signalling pathways and their possible interplay are incompletely understood. This study aims to assess the relative role of hyperglycemia and hyperinsulinemia alone or in combination on the gene expression patterning in the retina of animal models of diabetes. Material and methods As insulinopenic, hyperglycemic model reflecting type 1 diabetes, male STZ-Wistar rats (60mg/kg BW; i.p. injection at life age week 7) were used. Male obese ZDF rats (fa/fa) were used as type-2 diabetes model characterized by persisting hyperglycemia and transient hyperinsulinemia. Male obese ZF rats (fa/fa) were used reflecting euglycemia and severe insulin resistance. All groups were kept till an age of 20 weeks on respective conditions together with appropriate age-matched controls. Unbiased gene expression analysis was performed per group using Affymetrix gene arrays. Bioinformatics analysis included analysis for clustering and differential gene expression, and pathway and upstream activator analysis. Gene expression differences were confirmed by microfluidic card PCR technology. Results The most complex genetic regulation in the retina was observed in ZDF rats with a strong overlap to STZ-Wistar rats. Surprisingly, systemic insulin resistance alone in ZF rats without concomitant hyperglycemia did not induce any significant change in retinal gene expression pattern. Pathway analysis indicate an overlap between ZDF rats and STZ-treated rats in pathways like complement system activation, acute phase response signalling, and oncostatin-M signalling. Major array gene expression changes could be confirmed by subsequent PCR. An analysis of upstream transcriptional regulators revealed interferon-γ, interleukin-6 and oncostatin-M in STZ and ZDF rats. CONCLUSIONS: Systemic hyperinsulinaemia without hyperglycemia does not result in significant gene expression changes in retina. In contrast, persistent systemic hyperglycemia boosts much stronger expression changes with a limited number of known and new key regulators. 
650 4 |a Complement system 
650 4 |a Diabetes mellitus 
650 4 |a Gene expression 
650 4 |a Gene regulation 
650 4 |a Hyperglycemia 
650 4 |a Obesity 
650 4 |a Regulator genes 
650 4 |a !506797260! 
700 1 |a Dietrich, Axel  |e VerfasserIn  |4 aut 
700 1 |a Herling, Andreas W.  |e VerfasserIn  |4 aut 
700 1 |a Hammes, Hans-Peter  |d 1955-  |e VerfasserIn  |0 (DE-588)102028353X  |0 (DE-627)691169772  |0 (DE-576)360007252  |4 aut 
700 1 |a Wohlfart, Paulus  |d 1962-  |e VerfasserIn  |0 (DE-588)172624428  |0 (DE-627)697558754  |0 (DE-576)13348355X  |4 aut 
773 0 8 |i Enthalten in  |t PLOS ONE  |d San Francisco, California, US : PLOS, 2006  |g 12(2017), 6, Artikel-ID e0178658, Seite 1-17  |h Online-Ressource  |w (DE-627)523574592  |w (DE-600)2267670-3  |w (DE-576)281331979  |x 1932-6203  |7 nnas  |a The role of insulin resistance in experimental diabetic retinopathy genetic and molecular aspects 
773 1 8 |g volume:12  |g year:2017  |g number:6  |g elocationid:e0178658  |g pages:1-17  |g extent:17  |a The role of insulin resistance in experimental diabetic retinopathy genetic and molecular aspects 
856 4 0 |u http://dx.doi.org/10.1371/journal.pone.0178658  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0178658  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180625 
993 |a Article 
994 |a 2017 
998 |g 102028353X  |a Hammes, Hans-Peter  |m 102028353X:Hammes, Hans-Peter  |d 60000  |d 61400  |e 60000PH102028353X  |e 61400PH102028353X  |k 0/60000/  |k 1/60000/61400/  |p 4 
998 |g 1161675299  |a Järgen, Patrick  |m 1161675299:Järgen, Patrick  |d 60000  |d 61400  |e 60000PJ1161675299  |e 61400PJ1161675299  |k 0/60000/  |k 1/60000/61400/  |p 1  |x j 
999 |a KXP-PPN157679735X  |e 3013567325 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"given":"Patrick","role":"aut","family":"Järgen","display":"Järgen, Patrick"},{"given":"Axel","role":"aut","family":"Dietrich","display":"Dietrich, Axel"},{"family":"Herling","display":"Herling, Andreas W.","given":"Andreas W.","role":"aut"},{"role":"aut","given":"Hans-Peter","display":"Hammes, Hans-Peter","family":"Hammes"},{"family":"Wohlfart","display":"Wohlfart, Paulus","given":"Paulus","role":"aut"}],"id":{"eki":["157679735X"],"doi":["10.1371/journal.pone.0178658"]},"relHost":[{"corporate":[{"display":"Public Library of Science","role":"isb"}],"part":{"extent":"17","volume":"12","year":"2017","pages":"1-17","issue":"6","text":"12(2017), 6, Artikel-ID e0178658, Seite 1-17"},"language":["eng"],"disp":"The role of insulin resistance in experimental diabetic retinopathy genetic and molecular aspectsPLOS ONE","type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"PLOS ONE","title_sort":"PLOS ONE"}],"origin":[{"publisherPlace":"San Francisco, California, US ; Lawrence, Kan.","publisher":"PLOS ; PLoS","dateIssuedKey":"2006","dateIssuedDisp":"2006-"}],"pubHistory":["1.2006 -"],"note":["Schreibweise des Titels bis 2012: PLoS ONE","Gesehen am 20.03.19"],"id":{"eki":["523574592"],"zdb":["2267670-3"],"issn":["1932-6203"]},"recId":"523574592","physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["Public Library of Science"]}}],"recId":"157679735X","name":{"displayForm":["Patrick Järgen ; Axel Dietrich ; Andreas W. Herling ; Hans-Peter Hammes ; Paulus Wohlfart"]},"physDesc":[{"extent":"17 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"June 2, 20217"}],"note":["Published: June 2, 2017","Gesehen am 25.06.2018"],"title":[{"subtitle":"genetic and molecular aspects","title_sort":"role of insulin resistance in experimental diabetic retinopathy","title":"The role of insulin resistance in experimental diabetic retinopathy"}]} 
SRT |a JAERGENPATROLEOFINSU2202